154 related articles for article (PubMed ID: 20591421)
1. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
[TBL] [Abstract][Full Text] [Related]
3. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
[TBL] [Abstract][Full Text] [Related]
4. Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation.
Chen W; Xia C; Cai L; Wang PG
Bioorg Med Chem Lett; 2010 Jul; 20(13):3859-62. PubMed ID: 20627566
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of RCAI-172 (C6 epimer of RCAI-147) and its biological activity.
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Bioorg Med Chem; 2014 Jan; 22(2):827-33. PubMed ID: 24360828
[TBL] [Abstract][Full Text] [Related]
8. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
[TBL] [Abstract][Full Text] [Related]
9. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
[TBL] [Abstract][Full Text] [Related]
10. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
[TBL] [Abstract][Full Text] [Related]
11. Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators.
Harrak Y; Barra CM; Delgado A; Castaño AR; Llebaria A
J Am Chem Soc; 2011 Aug; 133(31):12079-84. PubMed ID: 21728320
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.
Nakagawa R; Motoki K; Nakamura H; Ueno H; Iijima R; Yamauchi A; Tsuyuki S; Inamoto T; Koezuka Y
Oncol Res; 1998; 10(11-12):561-8. PubMed ID: 10367937
[TBL] [Abstract][Full Text] [Related]
15. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.
Ndonye RM; Izmirian DP; Dunn MF; Yu KO; Porcelli SA; Khurana A; Kronenberg M; Richardson SK; Howell AR
J Org Chem; 2005 Dec; 70(25):10260-70. PubMed ID: 16323834
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Dideoxy-3,3,4,4-tetrafluoro- and 4-OH epimeric 3-deoxy-3,3-difluoro-α-GalCer analogues: Synthesis and biological evaluation on human iNKT cells stimulation.
Golten S; Patinec A; Akoumany K; Rocher J; Graton J; Jacquemin D; Le Questel JY; Tessier A; Lebreton J; Blot V; Pipelier M; Douillard JY; Le Pendu J; Linclau B; Dubreuil D
Eur J Med Chem; 2019 Sep; 178():195-213. PubMed ID: 31185411
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
